Safety of FURESTEM-CD Inj. in Patients With Moderate to Severe Plaque-type Psoriasis

NCT02918123 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

BIOLOGICAL: FURESTEM-CD Inj.

Sponsor

Kang Stem Biotech Co., Ltd.